MFluidX

BioTech

Developer of microfluidic chips designed for the treatment of infectious diseases. The company’s chips are based on microfluidics and uses highly sensitive nucleic acid amplification targeting infectious disease outbreaks such as the Zika and Dengue viruses, enabling physicians to determine the concentration of pathogens and to diagnose diseases.

Address:
2515 Benvenue Avenue
Apartment 308
Berkeley, CA 94704
Website:
www.mfluidx.com